Off-label prescribing has entered standard treatments and is at the cutting edge of medical innovation, but it carries ...

Trump’s ‘terrorist’ label on drug cartels puts US businesses at risk of prosecution, say experts There are growing concerns ...

Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...

However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...

Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...

The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...

“There’s lots of ways to communicate to a GLP-1 user and anyone wanting to lose weight that the food is healthy, a smaller portion and a great source of protein and fiber. They’ll be able to recognize ...

Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its heart disease drug, setting the stage for the 23-year-old biotech's next phase of growth.

Retailer-owned beauty lines are gaining status as young and affluent consumers increasingly take to the category, which is ...